来源:@CGTNGlobalBusiness微博
#真财实料#【阿斯利康CEO:拟在华投资千亿元】阿斯利康全球首席执行官苏博科在接受CGTN主持人@关馨GX 采访时表示,由于中国市场的蓬勃发展以及中国在生物制药创新生态系统中的核心地位,阿斯利康计划在中国投入1000亿元以用于研发和生产。#阿斯利康将在华投资超1000亿元#AstraZeneca plans to invest 100 billion yuan ($14.38 billion) in China for research and production, thanks to the booming development of the Chinese market and China's fundamental role in innovation ecosystems, said Pascal Soriot, CEO of AstraZeneca, in an interview with CGTN's Guan Xin.